Vivos Therapeuticsinc Stock Probability of Future Stock Price Finishing Over 2.64
| VVOS Stock | USD 2.64 0.08 2.94% |
Vivos |
Vivos TherapeuticsInc Target Price Odds to finish over 2.64
The tendency of Vivos Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.64 | 90 days | 2.64 | over 95.66 |
Based on a normal probability distribution, the odds of Vivos TherapeuticsInc to move above the current price in 90 days from now is over 95.66 (This Vivos TherapeuticsInc probability density function shows the probability of Vivos Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.19 . This entails as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Vivos TherapeuticsInc will likely underperform. Additionally Vivos TherapeuticsInc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Vivos TherapeuticsInc Price Density |
| Price |
Predictive Modules for Vivos TherapeuticsInc
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vivos TherapeuticsInc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vivos TherapeuticsInc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Vivos TherapeuticsInc Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Vivos TherapeuticsInc is not an exception. The market had few large corrections towards the Vivos TherapeuticsInc's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Vivos TherapeuticsInc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Vivos TherapeuticsInc within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | -1.22 | |
β | Beta against NYSE Composite | 1.19 | |
σ | Overall volatility | 1.25 | |
Ir | Information ratio | -0.17 |
Vivos TherapeuticsInc Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vivos TherapeuticsInc for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vivos TherapeuticsInc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Vivos TherapeuticsInc generated a negative expected return over the last 90 days | |
| Vivos TherapeuticsInc has high historical volatility and very poor performance | |
| Vivos TherapeuticsInc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 13.8 M. Net Loss for the year was (13.58 M) with profit before overhead, payroll, taxes, and interest of 12.6 M. | |
| Vivos TherapeuticsInc currently holds about 17.83 M in cash with (11.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.77. | |
| Vivos TherapeuticsInc has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Reviewing TELA Bio Vivos Therapeutics - Defense World |
Vivos TherapeuticsInc Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vivos Stock often depends not only on the future outlook of the current and potential Vivos TherapeuticsInc's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vivos TherapeuticsInc's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.2 M | |
| Cash And Short Term Investments | 1.6 M |
Vivos TherapeuticsInc Technical Analysis
Vivos TherapeuticsInc's future price can be derived by breaking down and analyzing its technical indicators over time. Vivos Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Vivos TherapeuticsInc. In general, you should focus on analyzing Vivos Stock price patterns and their correlations with different microeconomic environments and drivers.
Vivos TherapeuticsInc Predictive Forecast Models
Vivos TherapeuticsInc's time-series forecasting models is one of many Vivos TherapeuticsInc's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Vivos TherapeuticsInc's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Vivos TherapeuticsInc
Checking the ongoing alerts about Vivos TherapeuticsInc for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Vivos TherapeuticsInc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Vivos TherapeuticsInc generated a negative expected return over the last 90 days | |
| Vivos TherapeuticsInc has high historical volatility and very poor performance | |
| Vivos TherapeuticsInc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 13.8 M. Net Loss for the year was (13.58 M) with profit before overhead, payroll, taxes, and interest of 12.6 M. | |
| Vivos TherapeuticsInc currently holds about 17.83 M in cash with (11.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.77. | |
| Vivos TherapeuticsInc has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Reviewing TELA Bio Vivos Therapeutics - Defense World |
Check out Vivos TherapeuticsInc Backtesting, Vivos TherapeuticsInc Valuation, Vivos TherapeuticsInc Correlation, Vivos TherapeuticsInc Hype Analysis, Vivos TherapeuticsInc Volatility, Vivos TherapeuticsInc History as well as Vivos TherapeuticsInc Performance. For more information on how to buy Vivos Stock please use our How to Invest in Vivos TherapeuticsInc guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Vivos Stock analysis
When running Vivos TherapeuticsInc's price analysis, check to measure Vivos TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos TherapeuticsInc is operating at the current time. Most of Vivos TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Vivos TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos TherapeuticsInc's price. Additionally, you may evaluate how the addition of Vivos TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Vivos TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivos TherapeuticsInc. If investors know Vivos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivos TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.14) | Revenue Per Share 11.318 | Quarterly Revenue Growth (0.18) | Return On Assets (0.88) | Return On Equity (5.21) |
The market value of Vivos TherapeuticsInc is measured differently than its book value, which is the value of Vivos that is recorded on the company's balance sheet. Investors also form their own opinion of Vivos TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Vivos TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivos TherapeuticsInc's market value can be influenced by many factors that don't directly affect Vivos TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vivos TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivos TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivos TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.